US Pharma MarketingSylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.
Dexcom gives CFO Jereme Sylvain expanded role
Dexcom gives CFO Jereme Sylvain expanded role is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive